Use of MRI for the routine diagnosis of musculoskeletal conditions in the U.S. will cost $2.5 billion by 2020. Echometrix’s advancement of ultrasound technology for the evaluation of musculoskeletal conditions will help to solve this problem by making ultrasound easier to use by the treating clinician. Workers, soldiers and athletes will all benefit from a more available and more objective evaluation at initial diagnosis and during rehabilitation

Our opportunity is well timed because ultrasound equipment miniaturization, cost reduction and improvements in image quality have dramatically expanded the useful applications for ultrasound in healthcare. One of the least penetrated markets for ultrasound is musculoskeletal, and major players in the ultrasound industry are very focused on this market.



Echometrix is a Wisconsin Qualified New Business Venture - qualified and in-state investors receive a 25% tax credit from the State of Wisconsin.

If you are interested in an investment opportunity with Echometrix,
contact Echometrix at admin@echo-metrix.com or call 608.217.2685